Avopef
etoposide
- Strength
- 500 mg/25mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Avyxa Pharma, LLC
ETOPOPHOS
etoposide phosphate
Listed by H2-Pharma, LLC
- Strength
- 100 mg/1
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Class
- Topoisomerase Inhibitor
What it contains
- Etoposide Phosphate 100 mg/1
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Topoisomerase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 61269-410 |
| FDA application | NDA020457 |
| RxNorm concept | 226719 |
| Package sizes listed | 1 |
| Marketed since | June 2009 |
Other products containing Etoposide
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Avopef
etoposide
- Strength
- 100 mg/5mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Avyxa Pharma, LLC
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection, Solution, Concentrate
- Class
- Topoisomerase Inhibitor
BluePoint Laboratories
Etoposide
- Strength
- 50 mg/1
- Form
- Capsule
- Class
- Topoisomerase Inhibitor
Mylan Pharmaceuticals Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Accord Healthcare Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Hikma Pharmaceuticals USA Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection, Solution, Concentrate
- Class
- Topoisomerase Inhibitor
Meitheal Pharmaceuticals Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Hikma Pharmaceuticals USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.